Moderna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar. Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Broke support but with a doji - indicating uncertainty. Can still close above trend line tomorrow. 10 < 30< 50 < 100, however ADX indicates it's not a trend yet. However I am bearish
XLI consolidating sides on both sides of 50 and 100 dema
ADX ~8.8 10 dsma > 30 dema > 50 dema > 100 dema Expect resistance near 25
Recently lows were higher lowers. ADX ~17, so not considered a strong trend. 10 dsma < 30dema and trading below 50 and 100 dema Expect a test in the 75.50 - 76 area
Close held above 30dema ADX at 11 Ranging between 76 and 77.50
ADX at 13, indicating it is not trending It headed south on Friday, when SPY opened below 50 dema. I may consider selling a short put spread below 109.5 resistance
Friday was 2nd day it closed below 49. 49 is acting as a support, but FXI has been drifting lower Currently below 49, and below 50dema 10dsma > 30dema, however gap is very small now. Not sure if I want to sell a put spread, or do long call. I would like to treat FXI as a speculative index, because the Chinese market is very speculative right now (in a...